T-Cell Lymphoma

Type: Keyphrase
Name: T-Cell Lymphoma
First reported Apr 17 2014 - Updated 21 hours ago - 3 reports

BioAlliance Pharma, Topotarget to merge to create a leading orphan oncology company

BioAlliance Pharma SA, an innovative company specialized in the development of drugs within orphan oncology diseases, and Topotarget A/S, a Scandinavian-based biopharmaceutical company, announced their intention to merge to create a leading orphan oncology ... [Published PharmaBiz - 21 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

New Hematopoietic Data Have Been Reported by Investigators at Mayo Clinic

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Investigators discuss new findings in Hematopoietic. According to news reporting out of Rochester, Minnesota, by NewsRx editors, research stated, "ReportA 50-year-old male with T-cell ... [Published NewsRX - 21 hours ago]
First reported Apr 16 2014 - Updated Apr 17 2014 - 1 reports

France's BioAlliance merges with Topotarget of Denmark

France's BioAlliance Pharma is merging with Topotarget of Denmark to create "a leading orphan oncology company".Under the terms of the agreement, Topotarget stockholders will receive two shares in the new entity for every 27 shares they owned. This represents ... [Published Pharma Times - Apr 16 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Alisertib for relapsed or refractory peripheral T-cell lymphoma – second and subsequent line

Alisertib is intended to be used as second and subsequent line therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma . It is an inhibitor of the aurora A kinase. Aurora A and aurora B kinases are commonly overexpressed in tumours ... [Published BioPortfolio - Apr 08 2014]
First reported Apr 05 2014 - Updated Apr 05 2014 - 1 reports

Family needs bone marrow transplant for dog

Sadie, a four-year-old boxer in Dickenson, N.D., is suffering from T-cell lymphoma and needs a bone marrow transplant. Her owner, Ashley Hurlbert, has taken to Facebook to find Sadie's siblings. She uncovered Sadie's parents in Fargo, N.D., but they didn't ... [Published Click2Houston.com - Apr 05 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Mogamulizumab demonstrated activity in T-cell lymphomas

The anti-CC chemokine receptor 4 antibody mogamulizumab demonstrated antitumor activity among patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma, according to phase 2 study results.The analysis included 37 patients with anti-CC ... [Published Orthopedics Today - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Marek's disease virus and skin interactions

: Marek's disease virus (MDV) is a highly contagious herpesvirus which induces T-cell lymphoma in the chicken. This virus is still spreading in flocks despite forty years of vaccination, with important economical losses worldwide.The feather follicles, ... [Published 7thSpace - Apr 03 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Topotarget confirms receipt of acceptance-to-file milestone payment

To NASDAQ OMX Copenhagen A/S Announcement no. 03-14 / Copenhagen, March 26, 2014 Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and ... [Published NASDAQ OMX - Mar 26 2014]
First reported Mar 18 2014 - Updated Mar 19 2014 - 2 reports

Kyowa Hakko Kirin's POTELIGEO Injection approved for PTCL and CTCL in Japan

Japanese pharmaceutical firm Kyowa Hakko Kirin has received approval from the Japan's Ministry of Health, Labour and Welfare (MHLW) for additional indication for relapsed or refractory CCR4-positive peripheral T-cell lymphoma (PTCL) and cutaneous T-cell ... [Published Pharmaceutical Business Review - Mar 19 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 1 reports

Primary Pulmonary T-Cell Lymphoma Presenting as Bilateral Interstitial Infiltrates

SESSION TITLE: Cancer Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Primary pulmonary lymphomas are uncommon, and most frequently of B-cell lineage. Primary T-cell lymphoma ... [Published CHEST - Mar 18 2014]
First reported Mar 15 2014 - Updated Mar 15 2014 - 2 reports

Forum Post: Re: My adult daughter has been diagnosed with Peripheral T-cell lymphoma.

Parents of children with cancerThis group is designed to provide support to parents who are struggling with their child's cancer. This includes adult children who have cancer.My adult daughter has been diagnosed with Peripheral T-cell lymphoma.Posted ... [Published Macmillan Cancer Support - Mar 15 2014]
First reported Feb 07 2014 - Updated Feb 08 2014 - 2 reports

US FDA accepts Spectrum Pharma's NDA filing for pan-HDAC inhibitor, Beleodaq

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in haematology and oncology, has received the US Food and Drug Administration (FDA) acceptance of its New Drug Application ... [Published PharmaBiz - Feb 08 2014]

Quotes

Our news journalists obtained a quote from the research from Mayo Clinic, "The first two collections... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."
Patrick Langlois, Chairman of the Board of Directors of BioAlliance Pharma, said: "Merging with Topotarget is a major milestone for BioAlliance Pharma. This transaction will result in a new and true leader in orphan oncology. I am confident that, under the leadership of Judith Greciet, the new entity will unleash its full potential and create value for our shareholders."
"We are confident that this merger will deliver to our shareholders the best possible value and the opportunity to jointly shape a dynamic new player in the orphan oncology market" Vadsholt said
...According to news reporting from Tokyo, Japan , by NewsRx journalists, research stated, "Fibroblast growth factors (FGFs) are involved in a variety of cellular processes, such as stemness, proliferation, anti-apoptosis, drug resistance, and angiogenesis. Here, FGF signaling network, cancer genetics/genomics of FGF receptors (FGFRs), and FGFR-targeted therapeutics will be reviewed."

More Content

All (60) | News (57) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
BioAlliance Pharma, Topotarget to merge to crea... [Published PharmaBiz - 21 hours ago]
New Hematopoietic Data Have Been Reported by In... [Published NewsRX - 21 hours ago]
BioAlliance Pharma and Topotarget to Merge [Published Individual.com - 21 hours ago]
BioAlliance Pharma and Topotarget join forces t... [Published Pharmaceutical Technology - Apr 17 2014]
CANCER GENETICS : Data on Health and Medicine D... [Published 4 Traders - Apr 17 2014]
Celgene : Patent Issued for Preparation of Romi... [Published 4 Traders - Apr 17 2014]
BioAlliance Pharma, Topotarget to merge [Published Center Watch - Apr 17 2014]
BioAlliance and Topotarget merge to focus on ra... [Published PMLive - Apr 16 2014]
BioAlliance Pharma and Topotarget merge to crea... [Published Pharma Letter - Apr 16 2014]
BioAlliance Pharma and Topotarget Announce Merg... [Published PharmaceuticalProcessing - Apr 16 2014]
France's BioAlliance merges with Topotarget of ... [Published Pharma Times - Apr 16 2014]
BioAlliance Pharma to merge with Topotarget [Published Manufacturing Chemist - Apr 16 2014]
Cancer drug company BioAlliance to buy Topotarget [Published Sharenet - Apr 16 2014]
Alisertib for relapsed or refractory peripheral... [Published BioPortfolio - Apr 08 2014]
Clear Dermatology Assures Best Possible Skin Tr... [Published Digital Journal - Apr 07 2014]
North Dakota family uses Facebook to find a bon... [Published Examiner.com - Apr 06 2014]
Family needs bone marrow transplant for dog [Published Click2Houston.com - Apr 05 2014]
Mogamulizumab demonstrated activity in T-cell l... [Published Orthopedics Today - Apr 04 2014]
Mantle Cell Lymphoma -- Still More Questions Th... [Published American Journal of Public Health - Apr 03 2014]
Marek's disease virus and skin interactions [Published 7thSpace - Apr 03 2014]
Metreleptin for injection: Orphan drug treats c... [Published Pharmacist.com - Apr 01 2014]
The selective cytotoxic anti-cancer properties ... [Published BMC - Mar 29 2014]
Reports from Roswell Park Cancer Institute Add ... [Published NewsRX - Mar 28 2014]
Is It Time to Buy These 2 Cancer-Fighting Compa... [Published Motley Fool - Mar 27 2014]
Topotarget confirms receipt of acceptance-to-fi... [Published NASDAQ OMX - Mar 26 2014]
Topotarget confirms receipt of acceptance-to-fi... [Published GlobeNewswire: Advertising News - Mar 26 2014]
TopoTarget A/S : confirms receipt of acceptance... [Published 4 Traders - Mar 26 2014]
Investigators at Okayama University Graduate Sc... [Published NewsRX - Mar 21 2014]
Inhibition of CDK4 Might Promote Lymphoma Devel... [Published Brightsurf Science News - Mar 21 2014]
Increased risk of early relapse when radiothera... [Published Brightsurf Science News - Mar 20 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The CEO of Aetna embraces quackery [Respectful ... [Published ScienceBlogs : Combined Feed - Jan 17 2014]
Everyone hates health insurance companies. At least, so it seems. Personally, I’ve had my issues with such companies myself, particularly when having to deal with them when they refuse to cover certain medical tests for my patients. Fortunately for me, ...
1

Press Releases

sort by: Date | Relevance
Topotarget confirms receipt of acceptance-to-fi... [Published GlobeNewswire: Advertising News - Mar 26 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.